• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名42岁埃塞俄比亚男子患遗传性出血性毛细血管扩张症,伴有严重贫血和高输出量心力衰竭:病例报告及文献综述

Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review.

作者信息

Solela Gashaw, Adamseged Michael, Mohammed Abdulsemed

机构信息

Department of Internal Medicine Yekatit 12 Hospital Medical College Addis Ababa Ethiopia.

Division of Gastroenterology and Hepatology, Department of Internal Medicine College of Health Sciences, Addis Ababa University Addis Ababa Ethiopia.

出版信息

Clin Case Rep. 2023 Jul 12;11(7):e7694. doi: 10.1002/ccr3.7694. eCollection 2023 Jul.

DOI:10.1002/ccr3.7694
PMID:37448947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10337522/
Abstract

KEY CLINICAL MESSAGES

Hereditary hemorrhagic telangiectasia (HHT), a rare hereditary disorder, can cause recurrent massive epistaxis and gastrointestinal bleeding leading to severe anemia. Early diagnosis of HHT is essential to provide timely interventional therapies.

ABSTRACT

HHT is a rare autosomal dominant hereditary disease that results in abnormal vasculogenesis in the skin, mucous membranes, and visceral organs such as the liver, lungs, and brain. Clinical diagnosis of HHT is made using the Curacao criteria, which include recurrent spontaneous nosebleeds, mucocutaneous telangiectasias, visceral organ involvement, and first-degree family history of HHT. Here, we report a patient with HHT from Ethiopia, who presented with recurrent epistaxis and gastrointestinal bleeding, and severe anemia requiring frequent blood transfusions as well as cauterization. The presented case is a 42-year-old Black Ethiopian man with frequent hospitalization for severe anemia and high-output heart failure requiring frequent blood transfusions. His mother had bilateral epistaxis since her early adulthood. Physical examination was significant for tachycardia, pale conjunctivae, and tiny erythematous lesions over his tongue, ejection systolic murmur and peripheral edema. Laboratory investigations revealed severe anemia with iron deficiency picture. Upper gastrointestinal endoscopy showed multiple telangiectasia spots and abdominal Doppler ultrasound showed hepatic arterio-venous malformations. He received supportive management and electrocauterization of nasal, gastric, and duodenal telangiectasias. To the best of our knowledge, this is the first case of HHT to be reported from Ethiopia. High degree of suspicion and early diagnosis of HHT is essential to start preventive screening and surveillance and provide timely interventional therapies. HHT can cause recurrent massive epistaxis and gastrointestinal bleeding leading to severe anemia and high-output heart failure. In resource limited settings, selective cauterization of telangiectasia will help to control bleeding, although it does not avoid recurrent bleeding.

摘要

关键临床信息

遗传性出血性毛细血管扩张症(HHT)是一种罕见的遗传性疾病,可导致反复大量鼻出血和胃肠道出血,进而引起严重贫血。HHT的早期诊断对于及时提供介入治疗至关重要。

摘要

HHT是一种罕见的常染色体显性遗传病,可导致皮肤、黏膜以及肝脏、肺和脑等内脏器官血管生成异常。HHT的临床诊断采用库拉索标准,包括反复自发性鼻出血、黏膜皮肤毛细血管扩张、内脏器官受累以及HHT的一级家族史。在此,我们报告一名来自埃塞俄比亚的HHT患者,该患者出现反复鼻出血和胃肠道出血,以及严重贫血,需要频繁输血和烧灼治疗。该病例为一名42岁的埃塞俄比亚黑人男性,因严重贫血和高输出量心力衰竭频繁住院,需要频繁输血。他的母亲自成年早期就有双侧鼻出血。体格检查发现心动过速、结膜苍白、舌头上有微小的红斑病变、喷射性收缩期杂音和外周水肿。实验室检查显示严重贫血且有缺铁表现。上消化道内镜检查显示多个毛细血管扩张斑,腹部多普勒超声显示肝动静脉畸形。他接受了支持治疗以及对鼻腔、胃和十二指肠毛细血管扩张的电烧灼治疗。据我们所知,这是埃塞俄比亚报告的首例HHT病例。对HHT保持高度怀疑并进行早期诊断对于开展预防性筛查和监测以及及时提供介入治疗至关重要。HHT可导致反复大量鼻出血和胃肠道出血,进而引起严重贫血和高输出量心力衰竭。在资源有限的环境中,选择性烧灼毛细血管扩张有助于控制出血,尽管无法避免反复出血。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/427c6bc667ed/CCR3-11-e7694-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/cef94a3cfaea/CCR3-11-e7694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/9a20844aefa5/CCR3-11-e7694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/424168528c06/CCR3-11-e7694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/427c6bc667ed/CCR3-11-e7694-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/cef94a3cfaea/CCR3-11-e7694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/9a20844aefa5/CCR3-11-e7694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/424168528c06/CCR3-11-e7694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d5/10337522/427c6bc667ed/CCR3-11-e7694-g004.jpg

相似文献

1
Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review.一名42岁埃塞俄比亚男子患遗传性出血性毛细血管扩张症,伴有严重贫血和高输出量心力衰竭:病例报告及文献综述
Clin Case Rep. 2023 Jul 12;11(7):e7694. doi: 10.1002/ccr3.7694. eCollection 2023 Jul.
2
[Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].[贝伐单抗:遗传性出血性毛细血管扩张症治疗的新突破]
Rev Med Interne. 2015 Sep;36(9):623-5. doi: 10.1016/j.revmed.2014.11.004. Epub 2015 Jan 13.
3
[Iron deficiency anemia in a patient with hereditary hemorrhagic telangiectasia. Case report].[遗传性出血性毛细血管扩张症患者的缺铁性贫血。病例报告]
Ter Arkh. 2023 Sep 29;95(7):580-585. doi: 10.26442/00403660.2023.07.202303.
4
A Rare Case of Upper Gastrointestinal Bleeding: Osler-Weber-Rendu Syndrome.罕见的上消化道出血病例:Osler-Weber-Rendu 综合征。
Medicina (Kaunas). 2022 Feb 22;58(3):333. doi: 10.3390/medicina58030333.
5
Hereditary Hemorrhagic Telangiectasia遗传性出血性毛细血管扩张症
6
A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report.遗传性出血性毛细血管扩张症一例:病例报告
Cureus. 2022 Apr 27;14(4):e24517. doi: 10.7759/cureus.24517. eCollection 2022 Apr.
7
Hereditary Hemorrhagic Telangiectasia: A Rare Cause of Anemia.遗传性出血性毛细血管扩张症:贫血的罕见病因。
Cureus. 2019 Aug 8;11(8):e5349. doi: 10.7759/cureus.5349.
8
Digital Clubbing in Hereditary Hemorrhagic Telangiectasia/Juvenile Polyposis Syndrome.遗传性出血性毛细血管扩张症/青少年息肉综合征的杵状指(趾)。
Acta Dermatovenerol Croat. 2021 Apr;291(1):56-57.
9
Clinical Practice Guideline: Nosebleed (Epistaxis).临床实践指南:鼻出血(鼻衄)。
Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327.
10
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.临床实践指南:鼻出血(鼻衄)执行摘要。
Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955.

引用本文的文献

1
Clinical Study and Management of Epistaxis.鼻出血的临床研究与管理
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4348-4355. doi: 10.1007/s12070-024-04857-8. Epub 2024 Jul 13.

本文引用的文献

1
Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence.对遗传性出血性毛细血管扩张症(HHT)患者进行肺部和脑血管畸形筛查是北美地区的标准治疗方案:一项对卓越HHT中心的调查。
Vasc Med. 2021 Feb;26(1):53-55. doi: 10.1177/1358863X20974452. Epub 2020 Dec 29.
2
European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT).欧洲罕见血管疾病参考网络(VASCERN)遗传性出血性毛细血管扩张症(HHT)结局指标。
Orphanet J Rare Dis. 2018 Aug 15;13(1):136. doi: 10.1186/s13023-018-0850-2.
3
Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.
遗传性出血性毛细血管扩张症:从血液学家的角度诊断和管理。
Haematologica. 2018 Sep;103(9):1433-1443. doi: 10.3324/haematol.2018.193003. Epub 2018 May 24.
4
Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population.《Curaçao 标准在儿科人群遗传性出血性毛细血管扩张症诊断中的适用性》。
J Pediatr. 2018 Jun;197:207-213. doi: 10.1016/j.jpeds.2018.01.079. Epub 2018 Apr 11.
5
Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.遗传性出血性毛细血管扩张症(HHT)的胃肠道表现:文献系统综述
Dig Dis Sci. 2017 Oct;62(10):2623-2630. doi: 10.1007/s10620-017-4719-3. Epub 2017 Aug 23.
6
Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症贫血的患病率及预测因素
Am J Hematol. 2017 Jun 22. doi: 10.1002/ajh.24832.
7
Optimal management of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的优化管理
J Blood Med. 2014 Oct 15;5:191-206. doi: 10.2147/JBM.S45295. eCollection 2014.
8
The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study.英国遗传性出血性毛细血管扩张症的流行情况及其与性别、社会经济地位和居住地区的关系:一项基于人群的研究。
Thorax. 2014 Feb;69(2):161-7. doi: 10.1136/thoraxjnl-2013-203720. Epub 2013 Nov 4.
9
A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab.一例先后使用沙利度胺和贝伐单抗治疗的遗传性出血性毛细血管扩张症患者的病例报告。
Case Rep Oncol. 2010 Sep;3(3):463-70. doi: 10.1159/000323152. Epub 2010 Dec 11.
10
Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.遗传性出血性毛细血管扩张症:病理生理学、诊断与治疗。
Blood Rev. 2010 Nov;24(6):203-19. doi: 10.1016/j.blre.2010.07.001. Epub 2010 Sep 25.